Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Eva Rossmann, Anders Österborg, Eva Löfvenberg, Aniruddha Choudhury, Ulf Forssmann, Stefanie Senger, Andreas Schröder, Håkan Mellstedt

Blood (2011) 118 (21): 2927.

https://doi.org/10.1182/blood.V118.21.2927.2927

Published: 2011

Journal Articles

Immunological Responses in CLL Patients Vaccinated with Autologous Dendritic Cells Loaded with Apoptotic Bodies (Apo-DC).

Aniruddha Choudhury, MSc, PhD, Marzia Palma, M.D., Lotta Hansson, M.D., Ph.D., Karin Widen, Ingrid Eriksson, Barbro Nasman-Glaser, Lars Adamson, Anders Osterborg, M.D., Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2007) 110 (11): 2061.

https://doi.org/10.1182/blood.V110.11.2061.2061

Published: 2007

Journal Articles

Comparison of Gene Expression between T Cells from CLL Patients, Myeloma Patients and Healthy Individuals.

Aniruddha Choudhury, MSc, PhD, Anders Osterborg, M.D., Ph.D., Kaveh Mashayakhi, Ph.D., Ali Mosfegh, Ph.D., Shahryar Kiaii, Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2007) 110 (11): 4674.

https://doi.org/10.1182/blood.V110.11.4674.4674

Published: 2007

Journal Articles

Comparison of Antigen-Loading Strategies for DC-Based Immunotherapy of B-CLL.

Hakan Mellstedt, M.D., Ph.D., Parviz Kokhaei, B.S., Anders Osterborg, M.D., Ph.D., Aniruddha Choudhury, Ph.D.

Blood (2004) 104 (11): 4821.

https://doi.org/10.1182/blood.V104.11.4821.4821

Published: 2004

Journal Articles

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Aniruddha Choudhury, Ph.D., Katja Derkow, B.S., Eva Mikaelsson, B.S., Parviz Kokhaei, B.S, Anders Österborg, M.D., Ph.D., Hodjattallah Rabbani, Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2004) 104 (11): 176.

https://doi.org/10.1182/blood.V104.11.176.176

Published: 2004

Journal Articles

Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Aniruddha Choudhury, James L. Gajewski, Jan C. Liang, Uday Popat, David F. Claxton, Kay-Oliver Kliche, Michael Andreeff, Richard E. Champlin

Blood (1997) 89 (4): 1133–1142.

https://doi.org/10.1182/blood.V89.4.1133

Published: 1997

NARROW

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Immunological Responses in CLL Patients Vaccinated with Autologous Dendritic Cells Loaded with Apoptotic Bodies (Apo-DC).

Comparison of Gene Expression between T Cells from CLL Patients, Myeloma Patients and Healthy Individuals.

Comparison of Antigen-Loading Strategies for DC-Based Immunotherapy of B-CLL.

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Immunological Responses in CLL Patients Vaccinated with Autologous Dendritic Cells Loaded with Apoptotic Bodies (Apo-DC).

Comparison of Gene Expression between T Cells from CLL Patients, Myeloma Patients and Healthy Individuals.

Comparison of Antigen-Loading Strategies for DC-Based Immunotherapy of B-CLL.

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only